Kikuchi H, Ohtsuka E, Ono K, Nakayama T, Saburi Y, Tezono K, Ogata M, Iwahashi M, Nasu M
Second Department of Internal Medicine, Oita Medical University, Hasama-Oita, Japan.
Bone Marrow Transplant. 2000 Dec;26(11):1235-7. doi: 10.1038/sj.bmt.1702698.
We report here the first case report of bone marrow transplantation (BMT)-related transmission of human T lymphotropic virus type-I (HTLV-I). Antibodies against HTLV-I-associated antigens (anti-HTLV-I) were detected in the serum from the BMT recipient 12 days post BMT. IgG against gag core proteins (anti-p19 and anti-p24) appeared earlier than IgM against gag and env proteins (anti-p19, anti-p24 and anti-gp46) during seroconversion. The data presented here differs from blood transfusion-related seroconversion. This phenomenon may be due to the engraftment of anti-HTLV-I producing cells from the donor.
我们在此报告首例与骨髓移植(BMT)相关的人类I型嗜T淋巴细胞病毒(HTLV-I)传播病例。在骨髓移植受者骨髓移植后12天的血清中检测到针对HTLV-I相关抗原的抗体(抗HTLV-I)。在血清转化过程中,针对gag核心蛋白的IgG(抗p19和抗p24)比针对gag和env蛋白的IgM(抗p19、抗p24和抗gp46)出现得更早。此处呈现的数据与输血相关的血清转化不同。这种现象可能是由于供体中产生抗HTLV-I的细胞植入所致。